Results for tag: "Xadago"

Xadago is a market within the context of Central Nervous System (CNS) drugs. It is a type of drug used to treat Parkinson's disease, a neurological disorder that affects movement. Xadago is a monoamine oxidase type B (MAO-B) inhibitor, which works by blocking the breakdown of dopamine in the brain. This helps to improve the symptoms of Parkinson's disease, such as tremors, stiffness, and difficulty with movement. Xadago is also used to treat depression and anxiety. The Xadago market is made up of a variety of companies, including Merck, Teva Pharmaceuticals, and Lundbeck. These companies produce and distribute Xadago, as well as other CNS drugs. They also provide support and resources to patients and healthcare professionals. Additionally, there are a number of research organizations and clinical trials that are dedicated to studying the effects of Xadago and other CNS drugs. Show Less Read more